Recent data from the Hong Kong Stock Exchange reveals a significant position change for BAYZED HEALTH (02609) on June 11. The total value of shares held in custody reached HK$1.491 billion, representing 22.39% of the company's shares.

A major shareholder of the company deposited 295 million shares with CITIC Securities Brokerage (Hong Kong), accounting for the same 22.39% holding ratio.

For the six-month interim period ending December 31, 2024, BAYZED HEALTH reported revenue of RMB 575 million, marking a slight year-on-year increase of 0.66%.

However, the loss attributable to shareholders widened significantly to RMB 27.62 million, an increase of 139.18% compared to the same period last year. The basic loss per share was RMB 0.02.